Preventing stroke: saving lives around the world

Lancet Neurology

Volumn 6, Issue 2, 2007, Pages 182-187

  Strong, Kathleen ^a   Mathers, Colin ^a   Bonita, Ruth ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNATIONAL COOPERATION; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; HUMANS; INTERNATIONAL COOPERATION; PRIMARY PREVENTION; STROKE; WORLD HEALTH;

EID: 33846245504     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70031-5     Document Type: Review

References (32)

1. Lopez A., Mathers C., Ezzati M., Jamison D., and Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Strong K., Mathers C., Leeder S., and Beaglehole R. Preventing chronic diseases: how many lives can we save?. Lancet 366 (2005) 1578-1582
3. World Health Organization. The World Health Report 2004: changing history (2004), WHO, Geneva
4. Mathers C., Lopez A., and Murray C. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez A., Mathers C., Ezzati M., Murray C., and Jamison D. (Eds). Global burden of disease and risk factors (2006), Oxford University Press, New York 45-240
5. Salomon J., and Murray C. The epidemiologic transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev 28 (2002) 205-228
6. Feigin V., Lawes C., Bennett D., and Anderson C. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003) 43-53
7. Sarti C., Rastenyte D., Cepaitis Z., and Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 31 (2000) 1588-1601
8. Barendregt J., van Oortmarssen G., Vos T., and Murray C. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 1 (2003) 4
9. Mathers C., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 (2006) 442
10. Mathers C., Salomon J., Ezzati M., Begg S., and Lopez A. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. In: Lopez A., Mathers C., Ezzati M., Murray C., and Jamison D. (Eds). Global burden of disease and risk factors (2006), Oxford University Press, New York 399-426
11. Murray C., Mathers C., and Salomon J. Towards evidence-based public health. In: Murray C., and Evans D. (Eds). Health systems performance assessment: debates, methods and empiricism (2003), WHO, Geneva
12. Asplund K. What MONICA told us about stroke. Lancet Neurol 4 (2005) 64-68
13. Truelsen T., Mähönen M., Tolonen H., Asplund K., Bonita R., and Vanuzzo D. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 34 (2003) 1346-1352
14. Sarti C., Stegmayr B., Tolonen H., Mähönen M., Tuomilehto J., and Asplund K. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke 34 (2003) 1833
15. Whiteley W., Lindley R., Wardlaw J., and Sandercock P. Clinical trial protocols: third international stroke trial. Int J Stroke 1 (2006) 172-176
16. Warlow C., Sudlow C., Dennis M., Wardlaw J., and Sandercock O. Stroke. Lancet 362 (2003) 1211-1224
17. Chen Z., Sandercock P., Pan H., et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 31 (2000) 1240-1249
18. Mendis S., Abegunde D., Yusuf S., et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE). Bull World Health Organ 83 (2005) 820-828
19. World Health Organization. Preventing chronic diseases: a vital investment (2005), World Health Organization, Geneva
20. Australian Institute of Health and Welfare. Mortality over the twentieth century in Australia: trends and patterns in major causes of death-Mortality Surveillance Series No. 4 (2006), Australian Institute of Health and Welfare, Canberra
21. Ezzati M., Vander Hoorn S., Lopez D., et al. Comparative quantification of mortality and burden of disease attributable to selected risk factors. In: Lopez A., Mathers C., Ezzati M., Murray C., and Jamison D. (Eds). Global burden of disease and risk factors (2006), Oxford University Press, New York 241-268
22. Murray C., Lauer J., Hutubessy R., et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361 (2003) 717-725
23. Sargent R., Shepard R., and Glantz S. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 328 (2004) 977-980
24. Fichtenberg C., and Glantz S. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med 343 (2000) 1772-1777
25. Uusitalo U., Feskens E., Tuomilehto J., et al. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ 313 (1996) 1044-1046
26. Leth T., Jensen H., Ærendahl Mikkelsen A., and Bysted A. The effect of the regulation on trans fatty acid content in Danish food: First International Symposium on Trans Fatty Acids and Health. Sept 11-13, 2005: Rungstedgaard, Denmark. Elsevier. Atherosclerosis Supplements 7 (2006) 53-56
27. Zatonski W., McMichael A., and Powles J. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 316 (1998) 1047-1051
28. Dunn A., Andersen R., and Jakicic J. Lifestyle physical activity interventions: history, short-and long-term effects and recommendations. Am J Prev Med 15 (1998) 398-412
29. Lavados P., Sacks C., Prina L., et al. Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). Lancet 365 (2005) 2206-2215
30. Truelsen T., Bonita R., and Jamrozik K. Surveillance of stroke: a global perspective. Int J Epidemiol 30 (2001) S11-S16
31. Bonita R., Mendis S., Truelsent T., Bogousslavsky J., Toole J., and Yatsu F. The global stroke initiative. Lancet Neurol 3 (2004) 391-393
32. World Health Organization. STEPwise approach to stroke surveillance. http://www.who.int/chp/steps/stroke (accessed Nov 27, 2006).